leadf
logo-loader
AQSE:APOL

Apollon Formularies

Receive alerts
Market:
AQSE
Market Cap:
-
Price
2.70 GBX
Change
-1.82%
52 weeks high
-
52 weeks low
-

In brief

Apollon is a fully licensed, fully regulated medical cannabis company working with full spectrum oils inclusive of THC. The company plans, using its own formulations, to develop medicines for conditions that afflict humans in the modern world.

Snapshot

  • Apollon Formularies expands Jamaica production facility
  • Apollon Formularies' says new state-of-the art distiller increases production more than 50-fold

Insight Widest with the analysis, Proactive gives perspectives that others don't.